NanoValent Pharmaceuticals, Inc.
Bozeman, MT, 59718-4012
|# of Employees:||2|
|Socially and Economically Disadvantaged:||N|
DESCRIPTION provided by applicant This Phase I STTR project seeks to demonstrate proof of principle that novel targetable nanoparticles can delivery therapeutic substances to human tumor cells and ...STTRPhase I2016Department of Health and Human Services
DESCRIPTION provided by applicant The long term goal of this Phase I STTR project is to develop a commercially viable ultrasound contrast reagent UCR that will allow the noninvasive identificatio ...STTRPhase I2016Department of Health and Human Services
This Small Business Innovation Research Phase II project will develop targeted nanoparticle delivery systems capable of delivering conventional cytotoxics preferentially to tumor cells. While therapeu ...SBIRPhase II2013National Science Foundation
This Small Business Innovation Research (SBIR) Phase I project aims to explore the application of a targeted nanodelivery system for both treatment and efficacy monitoring in patients with adult leuke ...SBIRPhase I2012National Science Foundation